When it comes to weight loss, we’re all after a magic bullet, a simple, stress-free way of shedding the excess pounds. And so for millions around the world, the arrival of the so-called GLP-1 class of ...
They are the most talked-about pharmaceuticals of the last few years. GLP-1s are diabetes drugs that are exploding in popularity because of their weight loss properties. But how do GLP-1s actually ...
Industry report addresses OzemPatches ingredient disclosures, transdermal delivery claims, and what ad-exposed consumers ...
Industry Analysis Examines How FDA's First Oral GLP-1 Approval, Published Clinical Trial Data, and Evolving Telehealth Access ...
GLP-1 medications like Ozempic have dominated headlines over the past couple of years. When writing his new book, Diet, Drugs and Dopamine: The New Science of Achieving a Healthy Weight, former FDA ...
GLP-1 is a peptide hormone generated from proglucagon that is secreted after meals by enteroendocrine L-cells in the distal jejunum, ileum, and colon. GLP-1 is also produced by pancreatic α-cells and ...
As a 62-year-old grandmother in Maine, Christine Babb doesn’t identify with the biohacker bros who try experimental medications to optimize their health. But after side effects from her first dose of ...
Randomised trial data show GLP 1 receptor agonists are associated with increased risk of gallbladder and biliary disease, ...
These days, it seems like everywhere you go, someone’s talking about weight loss drugs. With the explosion in popularity of GLP-1 drugs like Ozempic, another industry has popped up, claiming to offer ...
In the realm of innovative health solutions, the HonXi SMGT-GLP-1 Nano Microneedle Patch stands out as a revolutionary approach to managing weight and controlling blood sugar levels. As the prevalence ...
Test your knowledge of GLP-1 medications and how they can help manage type 2 diabetes. Take our trivia quiz to see what you know about GLP-1 uses, benefits, and side effects. Share on Pinterest ...
GLP-1 drugs are expanding beyond diabetes to potentially reduce heart disease and improve sleep quality. Market for GLP-1 drugs is set to grow from $70 billion in 2025 to $157 billion by 2030, led by ...